跳至主要内容
临床试验/DRKS00017406
DRKS00017406已完成不适用

Indications and Safety Profile of Musculoskeletal Contrast-Enhanced Ultrasound with SonoVue®

Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie0 个研究点目标入组 800 人开始时间: 2019年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Data of study patients, who underwent musculoskeletal CEUS examinations with SonoVue® between 2012 and 2019, were included.

排除标准

  • Exclusion criteria for the utilization of CEUS were a history of recent myocardial infarction, an intracardial right-left shunt, uncontrollable fluctuations of blood pressure, severe respiratory disease (pulmonary arterial hypertension (PAH), severe acute respiratory syndrome (SARS), during pregnancy and while breast-feeding (missing studies, no evidence) or any known allergic reaction to SonoVue® as well as other similar contrast agents. Further exclusion criteria were an age younger than 18 years and the lack of the patients’ informed consent.

研究者

发起方
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie

相似试验